Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. (Q54321441)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 February 2012

edit

Language	Label	Description	Also known as
English	Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.	scientific article published on 28 February 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

title

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

main subject

biomarker

0 references

author

Shinya Matsuzaki

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

author name string

Satoshi Serada

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Minoru Fujimoto

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Fumitaka Terabe

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Hideki Iijima

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Shinichiro Shinzaki

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Tomoharu Ohkawara

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Riichiro Nezu

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Sachiko Nakajima

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Taku Kobayashi

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Scott Eric Plevy

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Tetsuo Takehara

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

Tetsuji Naka

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

publication date

28 February 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

published in

Inflammatory Bowel Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

page(s)

2169-2179

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

cites work

Diagnostics of inflammatory bowel disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Inflammatory bowel disease: clinical aspects and established and evolving therapies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Current management of severe ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Use of the Crohn's disease activity index in clinical trials of biological agents

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

C-reactive protein as a marker for inflammatory bowel disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Differing acute phase responses in Crohn's disease and ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIBD.22936

retrieved

21 January 2018

Identifiers

DOI

10.1002/IBD.22936

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

PubMed publication ID

22374925

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22374925

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22374925

ResearchGate publication ID

221870879

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54321441&oldid=788898345"